Centro Congressi Giovanni XXIII, Viale Papa Giovanni XXIII, 106, 2412, Bergamo, Italy
15 - 17 May 2019
This meeting aims to develop our understanding of the potential of liquid biopsies. This includes to support early detection of cancer; as prognostic, pharmacodynamic and predictive biomarkers of treatment efficacy and resistance; and for patient monitoring, including of minimal residual disease for early identification of disease relapse. It will also explore how liquid biopsies can be incorporated in cancer patient management and how implementation of liquid biopsies can change clinical practice.
|
|
|
Invited Speakers:
|
|
Nicola Aceto (Switzerland), Alberto Bardelli (Italy), Carlos Caldas (UK), Sarah-Jane Dawson (Australia), Johann de Bono (UK), Caroline Dive (UK), Mariam Jamal-Hanjani (UK), Evi Lianidou (Greece), Dennis Lo (Hong Kong), Klaus Pantel (Germany), Nickolas Papadopoulos (USA), Joan Seoane (Spain), Gabriella Sozzi (Italy), Michael Speicher (Austria)
|
|